London-based LabGenius, which uses ML to find and design antibody therapies to treat cancer, raised a £35M Series B led by Merck's VC arm, M Ventures — It's robotic platform is using machine learning to create new molecules to tackle cancer — UK drug discovery startup LabGenius …
Posted from: this blog via Microsoft Power Automate.